All terms in MESH
| Label | Id | Description |
|---|---|---|
| Caulobacteraceae | D042063 | [A family of stalked bacteria that reproduces by budding. There are four genera: CAULOBACTER, Asticcacaulis, Brevundimonas, and Phenylobacterium.] |
| Caulobacter crescentus | D016935 | [A species of gram-negative, aerobic bacteria that consist of slender vibroid cells.] |
| Gram-Positive Endospore-Forming Bacteria | D016936 | [Bacteria that form endospores and are gram-positive. Representative genera include BACILLUS; CLOSTRIDIUM; MICROMONOSPORA; SACCHAROPOLYSPORA; and STREPTOMYCES.] |
| Gram-Positive Bacteria | D006094 | [Bacteria which retain the crystal violet stain when treated by Gram's method.] |
| Endospore-Forming Bacteria | D004725 | [A group of rods or cocci whose taxonomic affinities are uncertain. They form endospores, thick-walled bodies formed within the vegetative cells of certain bacteria, able to withstand adverse environmental conditions for prolonged periods.] |
| Gram-Positive Rods | D016987 | [A large group of rod-shaped bacteria that retains the crystal violet stain when treated by Gram's method.] |
| Cardiac Care Facilities | D002300 | [Institutions specializing in the care of patients with heart disorders.] |
| Hospitals, Special | D006782 | [Hospitals which provide care for a single category of illness with facilities and staff directed toward a specific service.] |
| Cardiac Glycosides | D002301 | [Cyclopentanophenanthrenes with a 5- or 6-membered lactone ring attached at the 17-position and SUGARS attached at the 3-position. Plants they come from have long been used in congestive heart failure. They increase the force of cardiac contraction without significantly affecting other parameters, but are very toxic at larger doses. Their mechanism of action usually involves inhibition of the NA(+)-K(+)-EXCHANGING ATPASE and they are often used in cell biological studies for that purpose.] |
| Cardanolides | D002297 | [The aglycone constituents of CARDIAC GLYCOSIDES. The ring structure is basically a cyclopentanoperhydrophenanthrene nucleus attached to a lactone ring at the C-17 position.] |
| Cardiac Output | D002302 | [The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat).] |
| Hemodynamics | D006439 | [The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM.] |
| solophenol D | C578057 | |
| Cardiac Output, Low | D002303 | [A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.] |
| Heart Diseases | D006331 | [Pathological conditions involving the HEART including its structural and functional abnormalities.] |
| Signs and Symptoms | D012816 | [Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient.] |
| solophenol C | C578058 | |
| Cardiac Pacing, Artificial | D002304 | [Regulation of the rate of contraction of the heart muscles by an artificial pacemaker.] |
| solomonin | C578059 | |
| Cardiac Tamponade | D002305 | [Compression of the heart by accumulated fluid (PERICARDIAL EFFUSION) or blood (HEMOPERICARDIUM) in the PERICARDIUM surrounding the heart. The affected cardiac functions and CARDIAC OUTPUT can range from minimal to total hemodynamic collapse.] |